反応式
[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[C:4]([F:8])[C:3]=1[C:9]1[NH:13][C:12](=[O:14])[N:11]([C:15]2[CH:23]=[CH:22][C:18]([C:19]([OH:21])=O)=[CH:17][CH:16]=2)[N:10]=1.C(N(C(C)C)CC)(C)C.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.[F:55][C:56]1[CH:63]=[CH:62][C:59]([CH2:60][NH2:61])=[C:58]([C:64]([F:67])([F:66])[F:65])[CH:57]=1>C1COCC1>[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[C:4]([F:8])[C:3]=1[C:9]1[NH:13][C:12](=[O:14])[N:11]([C:15]2[CH:16]=[CH:17][C:18]([C:19]([NH:61][CH2:60][C:59]3[CH:62]=[CH:63][C:56]([F:55])=[CH:57][C:58]=3[C:64]([F:67])([F:65])[F:66])=[O:21])=[CH:22][CH:23]=2)[N:10]=1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
The title compound was prepared according to the procedure described in Example-17 by using 4-[3-(2-chloro-6-fluorophenyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzoic acid (Intermediate-9, 0.100 g, 0.30 mmol), THF (5 mL), di-isopropyl ethyl amine (2.0 mL), TBTU (0.177 g, 0.540 mmol) and 4-fluoro-2-trifluoromethyl benzylamine (0.089 g, 0.600 mmol) to afford 0.025 g of desired product. 1H NMR (300 MHz, DMSO d6): δ 4.63 (d, J=4.5 Hz, 2H), 7.48-7.50 (m, 6H), 8.05 (s, 4H), 9.16 (t, 1H), 12.67 (br, 1H); MS (m/z): 509.05 (M+H)+.
後処理
- customThe title compound was prepared
出典と根拠
- ORDレコード
- ord-fb7fa4800ab647869e0d4b39d4f80ce6
- 出典データセット
- uspto-grants-2015_08
- 特許番号
- US09096545B2
関連ノート
読み込み中…